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INTRODUCTION
Prom the time when the lupus erythematosus
cell was first described by Hargraves, Richmond,
and Morton1 there has been much speculation as to
what factors are responsible for its production.
Initially it v/as believed that the L.E.

cell was

was pathognomonic of lupus erythematosus.

As the

phenomenon became better known, however, various
workers reported the L.E. cell phenomenon in other
diseases ,’<:)
Early investigators of the L.E.

cell hypothe¬

sized that the phenomenon was due to a factor pres¬
ent in the blood plasma.

This theory was later

borne out by experiments which demonstrated that
the L.E. factor was present in the gamma globulin
r-i

fraction of the plasma proteins.1
Miescher has demonstrated that absorption of
lupus serum with isolated nuclei results in removal
or destruction of the L.E. factor.

A

Very recently

the fluorescent antibody technique has been applied
to this problem.

In the first report of such studies

it was shown in vitro that a globulin factor of
lupus serum adheres to nuclei in sections of tissue,
Further studies revealed that nucleoprotein might
be the nuclear factor involved in this reaction.
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The investigation to be reported here is an attempt
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to further elucidate this problem through the use
of isolated chromosomes and the fluorescent anti¬
body technique.

3
The L.B.
The L.B.
Richmond,

Cell

cell was first described by Hargraves,

and Morton in 194-8*

They often noted that

in the bone marrow of patients with lupus erythema¬
tosus a peculiar cell was to be found.

’’This cell

undoubtedly represents a process which is going on
in such bone marrows and is the end result of one
of two things:

either phagocytoses of free nuclear

material with a resulting round vacuole containing
this partially digested and lysed nuclear material
or,

second,

an actual autolysis of one or more lobes

of the nucleus of the involved cell so that it pre¬
sents essentially the same appearance as the one
which has phagocytized nuclear material.Hargraves,
Richmond,

and Morton concluded their description of

the L.E.

cell by suggesting that the finding of L.E.

cells in a patients’

bone marrow might be of some

help in diagnosing lupus erythematosis.

Shortly

after the publication of the original description
other workers reported finding such cells in patients
with systemic lupus erythematosis. A-L
For a time it was believed that these peculiar
cells were pathognomonic of disseminated lupus
erythematosis.

° Later investigations, however,

demonstrated that this was not true.

L.E.

cells

have been found in association with the ”collagen
diseases” and with drug hypersensitivity reactions
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as well.

In particular,

L.E.

cells have been
D

I,

described in periarteritis nodosa,-' penicillin’
and hydantoin- hypersensitivity,

as well as during

hydralazine therapy,0

The L.E, Cell Phenomenon
Until 19^9 the only reliable way in which L.E.
cells could be demonstrated was by aspiration and
examination of bone marrow.

If the bone marrow was

hypoplastic or the patient too ill for sternal
puncture this method of investigation had obvious
disadvantages.
that L.E.

In

I9I1.9

Haserick and Bortz found

cells could be produced by adding plasma

taken from patients "with acute disseminated lupus
erythematosis to heparinized normal bone marrow.^-2,13
It was also noted that leukocyte clumping was induced.
The discovery of the L.E. cell phenomenon was
very important because it shed light on a few basic
principles concerning the L.E.

cell.

First of all,

it revealed that the plasma of patients with acute
disseminated lupus erythematosus contained a factor
responsible for the formation of the L.E.
Secondly,

cell.

it also became apparent that the production

of the L.E. cell was a secondary rather than a pri¬
mary phenomenon
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The L.E.

Cell Factor

How that it had been established that the
formation of L.E.

cells was due to the presence of

a factor in the plasma the next step was to identify
the substance.

A few facts were already known con¬

cerning its nature.

Firstly,

it was stable for

periods of at least as long as six months provided
that the plasma was kept sterile.~~ It was destroyed
by heating the plasma to 65° C.

Para-aminobenzoic

acid seemed to inhibit the activity of the factor,
although this may have been due to a direct effect
of the acid on the bone marrow.

The factor could

not be detected in patients during a remission but
only during the acute phase of the disseminated
lupus erythematosus.

The factor could not be found

in patients suffering from rheumatic fever,
or chronic lupus erythematosis,
arthritis,

scleroderma,

subacute

cirrhosis, rheumatoid

dermatomyositis,

or peri¬

arteritis nodosa.Later workers, however, were
able to demonstrate the L.E. phenomenon in some of
these conditions and in other diseases as well.
In order to identify which portion of the blood
plasma contained the L.E, factor, Haserick,
and Bortz in 19^0,

Lewis,

employed fractionation by the

Tiselius electrophoretic technique.1

These investi¬

gators divided plasma from a patient with acute

.
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disseminated lupus erythematosis into several
fractions:

1)

albumin,

(3.5 mg.);

and beta globulin (12 mg.);
(2 mg.);
(Il.8

3)

2)

albumin,

alpha

gamma globulin

and 4) gamma globulin and fibrinogen

rug.).

Then,

by adding each fraction to normal

bone marrow and noting L.E.

cell formation,

it was

determined that only the gamma globulin fraction
contained the L.E. factor.
In an attempt to prove that the L.E. factor is
an immunologically distinct component of gamma
globulin, Haserick and Lewis conducted an ingenious

1g

experiment."

By electrophoresis they first sepa¬

rated the gamma globulin fraction from the plasma
obtained from a patient suffering with acute dissem¬
inated lupus erythematosis.

An antiserum against

this fraction was then produced by repeated in¬
jections of the gamma globulin into rabbits.

A

control rabbit antiserum against normal human gamma
globulin was also produced by the same method.
Next,

the investigators took a quantity of human

L.E. gamma globulin and divided It into two portions.
To one portion was added the antiserum to L.E. gamma
globulin,
antiserum.

and to the other was added the control
In both portions a precipitate formed

and was removed by centrifugation.

The supernatant
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7
fluid from each portion was then added to bone
marrow preparations which were subsequently examined
for L.E.

cell formation.

The L.E. gamma globulin

to which had been added the antiserum to normal
human gamma globulin caused the production of L.E.
cells.

On the other hand,

the L.E. gamma globulin

to which had been added antiserum to L.E. gamma
globulin was unable to induce L.E.

cell formation.

Although the above experiment has been widely
accepted as proof that the L.E. factor in gamma
globulin is a distinct immunological entity,

the

possibility of incomplete precipitation remains as
an alternative explanation.
At this point it would be appropriate to list
the salient properties of the L.E. factor as re¬
vealed by past investigations.

1.

The L.E.

factor is contained in the

gamma globulin fraction of the
blood plasma.
2.

The presence of the factor can be
demonstrated by adding L.S. plasma
to a normal bone marrow preparation
thus producing L.E.

cell formation

(this is referred to as the L.E.
cell phenomenon).
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3.

The L.E. factor is probably a distinct
immunological entity.

[f..

The L.E. factor has been found in
diseases other than acute dissem¬
inated lupus erythematosis, notably
in drug hypersensitivities and in
some of the other ’’collagen diseases."

5.

The factor induces nucleolysis and
nucleophagocytosis with the re¬
sulting production of an L.E.

cell.

. ,

.

. .
ion ,Glacis orWvxo qsjcls! beisnl

. .

'9.
Methods and Materials
The Fluorescent Dye Labeled Antibody Technique
The technique of labeling an antibody with a
dye so that the complex resulting from the combina¬
tion of this labeled antibody with its specific
antigen could be visualized was first successfully
accomplished by Reiner in 1930.

17
' Reiner was able

to chemically combine antipneumococcus I and II
antibodies and atoxyl-azo dyes.

He noted that the

dye-antiserum complex had the same agglutinative
titre as the original antiserum and that its mouseprotection activity was unaltered.
Marrack,

in I93J4.J reacted diazotized benzidine-

azo-R-salt with anti-typhoid and anti-cholera sera
and then demonstrated that the homologous organisms
*1 A

were stained pink by the dye-labeled antibodies."
In order to prove that the dye-typhoid antibody
complex was immunologically identical with the
original typhoid antiserum he performed a rather
clever experiment.

He mixed ordinary cholera anti¬

serum with an equal amount of the typhoid antiserumdye complex.

To one-half of this mixture he then

added typhoid bacilli.

The cholera vibrios were

agglutinated but unstained.

The typhoid bacilli,

on the other hand, were not only agglutinated but
also stained red.

This simple procedure demonstrated
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that the typhoid antiserum was immunologically
unaltered by the dye conjugation.
Coons,

Creech,

and Jones were the first to

combine an antiserum with a fluorescent moiety and
thus render the resulting antigen-antibody complex
In I9I1I they

fluorescent in ultraviolet light."'1'

prepared a B-anthryl-carbamide derivative of anti¬
pneumococcus III rabbit serum which produced a.
faint blue fluorescence in daylight and an intense
blue fluorescence in ultraviolet light.

At the

same time it was demonstrated that the conjugation
procedure in no way interfered with the specific
reactivity of the antiserum.
In 19I4.2,

Coons

and his group showed that a

fluorescein-carbamido-pneumococcal III antiserum
could specifically stain tissues from a mouse inO r\

fected with type III pneumococcus.

In 195>0,

Coons

and Kaplan reported improvements in the synthesis
of fluorescein Isocyanate which had been first
accomplished by Bogert and fright
later by Coons,

Breech,

Jones,

21

22
’

and modified

and Berliner.

-

At

the same time they also defined the optimum conditions
for combining the fluorescent isocyanate dye with
protein materials.
coccal rabbit serum,

They then conjugated antipneumotype III, with fluorescein

.
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isocyanate II by their improved technique.

The

fluorescent dye-labeled antipneumococcal antiserum
was then successfully used to locate pneumococcal
polysaccharides in the tissues of mice.

2li_
■

Many other investigators have employed the
Coons technique of combining antiserum with the
fluorescent dye,

fluorescein isocyanate,

in order

to locate a specific antigen in animal tissues.
Conjugates have been prepared to identify the capsular polysaccharide of Priedlander1s bacillus,
mumps virus,^ plasma proteins,
lytica,

28

Endamoeba histo-

and many other antigenic substances.

Figure I is a diagrammatic representation of
the Coons dye labeled antibody reactions.
A slightly more complex,
technique is often employed.
is dealing with an antigen,

but just as useful
If, for example,

one

the antibody to Yfoich

is located in the gamma globulin fraction of human
serum it is not necessary to make up a specific
dye-antibody conjugate against the antigen.

Instead,

a fluorescent antibody is ms.de up against human gamma
globulin.

Then,

any antibody from the gamma globulin

which combines with the antigen will,

in turn,

also

combine with the fluorescent antibody against the

.

.
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Figure I

a. The antibody with its specific receptor, 1,

is chemically combined with a fluorescent dye,
fluorescein isocyanate.

Dye
(fluorescent)

Antibody

Dye-antibody conjugate
(fluorescent)

b. To identify the specific antigen the dye-antibody
conjugate is then added:

Dye-antibody conjugate
(fluorescent)

Antigen

Conjugate-antigen
complex
(fluorescent)

-

13.

human gamma globulin.

Thus the original antigen

is labeled by a two stage process

(figure II).

In the work to be reported here, the techniques
just described were employed In attempts to demon¬
strate that a factor in lupus serum is capable of
combining with some material present in isolated
chromosomes.

The Isolation of Chromosomes
The chromosomes were isolated from chicken
erythrocytes, which are nucleated.

The method

used was that of Mir sky and Ris.c';

Blood was

obtained by cutting the chickenTs throat and col¬
lecting it in a bottle with oxalate.

The blood

(20 ml.) was then centrifuged for 15> minutes at
5000 rpm.

at a temperature of one degree centigrade.

The buffy coat and plasma were decanted and the
remaining red cells washed three times in 0.1 Ip M
NaCl.

Next,

the washed cells were mixed with ap¬

proximately 100 ml.
Oaring blendor,

of O.llp M NaCl, placed In a

and beaten for 20 minutes.

Ice

was packed around the outside of the blendor so
that the contents could be kept cool.

The re¬

sulting mixture was centrifuged for

minutes at
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FIGURE II

a. Antibody with its specific receptor 1,
species specific receptor, 2.

and its

Antibody A

b. The antibody against the gamma globulin species
specific recptor of antibody A is combined with a
dye, fluorescein isocyanate.

+
Dye
Antibody B
Dye-antibody B
(fluorescent) (against gamma globulin)
conjugate
(fluorescent)
c. To identify the specific antigen,
Tnon-fluorescent) is first added.

iJn +
Antibody A

l=L. “

Specific Antigen

antibody A

Antibody A-antigen
complex

d. lext, the dye-antibody B conjugate which is an
antibody against the species specific receptor of
antibody A is added.

Dye-antibody B
conjugate
(fluorescent)

Antibody A-antigen
complex

Conjugate-antibody Aantigen complex
(fluorescent)
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5000 rpin, the red supernatent fluid poured off,
and the precipitate,

consisting of chromosomes

which have been removed from the erythrocyte nucleus,
then washed with saline.

All solutions were kept

at approximately one degree centigrade during the
entire process.
To verify the presence of chromosomes in the
precipitate,

smears were made on slides and stained

by the Fuelgen method which is specific for nucleoprotein.

Chromosomes with their characteristic

morphology,

as described by Mirsky and Ris,

be identified.

could

26

Source of Human Sera
Serum was obtained fom patients who had been
diagnosed clinically as suffering from lupus erythem¬
atosus.

The sera used for these tests was known to

contain the factor,

described by Friou, which reacts

with intact nuclei.

Normal serum was also obtained.

The serum was frozen and stored at minus ten degrees
centigrade and thawed immediately before use.
The Fluorescent Antibody*
Anti-human globulin was produced by repeated
injection of an alum precipitated gamma globulin
-«*

The fluorescent conjugated antiglobulin was
provided by Dr. George J. Friou.

-

.
.

.

.

*

.

into rabbits.

The anti-human globulin was then

separated by ammonium sulfate fractionation from
the rest of the rabbit serum.

Next,

the anti-human

globulin was conjugated with fluorescein isocyanate
II.

The procedure used was that of Coons and Kaplan

as described in their paper of 1950.

21

The resulting

fluorescent rabbit anti-human, globulin proved to
have a precipitin titre of 1:10 against human globu¬
lin.

30
The Staining Procedure
A drop of the chromosome preparation was placed

on each of a series of slides.

The slides were dried

at room temperature for ten minutes at a distance
of three feet from an electric fan.
process had been completed,

After the drying

one drop of the thawed

lupus erythematosiis serum was applied to the dried
chromosome precipitate on each slide.

Next,

the

slides were Incubated for one half hour at room
temperature.

To prevent drying during the incubation

period these were placed in a covered pan with a
moist towel in the bottom.

The following step was

a washing procedure using phosphate buffer prepared
by adding IpO grams of sodium chloride to 6.9 grams
of sodium phosphate and mixing with enough distilled
water to give a volume of 5>000 cc.

The pH was

.

.
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.

-
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:
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adjusted to 7.0 with I4.O per cent NaOH.
After the washing has been completed,

the

slides were shaken once or twice to remove any
excess buffer.

One drop of tie fluorescent rabbit

anti-human globulin conjugate was then applied and
the slides incubated for one-half hour again,
the covered pan.
Then,

in

The washing procedure v/as repeated.

one drop of a glycerine-phosphate buffer

solution (1 ml.

of phosphate buffer plus 9 ml* of

glycerol) was added to each slide and cover slips
applied.

The slides were now ready to be examined.

Results
The chromosomes were seen to readily fluoresce
under the ultraviolet microscope

(plate 1.).

This

suggests that a specific complex has been formed in
the following sequence:

first the chromosomes bind

a factor in the gamma globulin fraction of the
lupus erythematosus serum,

then the fluorescent

rabbit anti-human gamma globulin attaches to the
gamma globulin.

The latter

combination is known to

be an antigen-antibody reaction.
Two controls were run in order to prove that a
specific combination had taken place between some
factor in the L.E.

serum and the chromosomes.

.

.

.
.-

.

•

•

.1

,

.

18

PLATE I

Chromosome stained with fluorescent antibody*
Due to the printing process the stain appeares blue
rather than the original green.

.
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1. ) Normal serum was substituted for the L.E.

serum

in the staining process. No fluorescence was observed,
2, ) L.E.

serum was absorbed with nucleoprotein in

the following manner:

calf thymus nucleoprotein was

precipitated by adding 170 ml,

of .177 M sodium

chloride solution to 100 ml. of calf thymus nuclear
extract and refrigerating at kO degrees P. for onehalf hour.

The precipitate was then washed with

.15 M sodium chloride solution and: centrifuged.
The absorption was accomplished by adding the nucleo¬
protein precipitate to 5 ml. of L.E,

serum and

letting the mixture stand at IpO degrees P.
later the L.E.

One hour

serum was decanted and the process

repeated with another batch of nucleoprotein precip¬
itate.

It was then determined that the absorbed

serum did not produce the L.E. phenomenon nor contain the factor which reacts with intact nuclei.

30

When the absorbed lupus serum was used in the
fluorescent staining process with chromosomes no
staining took place.

This

suggests that the material

in chromosomes with which the lupus globulin factor
reacts is nucleoprotein.
The final step in the investigation confirms
the impression that the material in chromosomes

. .
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which combines with the lupus serum, factor is indeed
nucleoprotein,

Mir sky and Ris found that chromosomes

could be fractionated into two parts by placing them

.^

in a neutral solution of 1 M sodium chloride

One

fraction,

the supernatent fluid, proved to be nucleo¬

protein.

The remaining insoluble precipitate, making

up 8 to 10 per cent of the chromosomal mass contained,
!l12 to lip per cent ribose nucleic and about one-fifth
as much desoxyribose nucleic acid.
method of Mirsky and Ris,

m2Q

7 Following the

the chicken erythrocyte

chromosomes were fractionated. The supernatant fluid,
virtually pure nucleoprotein, was dried on a slide
and stained by the fluorescent antibody technique
as outlined earlier#

The nucleoprotein stained brightly#

.
.

.

,

••

.

21

Summary
By use of Coons’
technique,

fluorescent antibody staining

it was demonstrated that a serum factor

from patients with lupus erythematosus adheres to
isolated chromosomes.

It was further shown that

this is due to a combination between the nucleoprotein of the chromosomes and the factor of the
serum

3
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